GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » Net Income From Continuing Operations

C&R Research (XKRX:359090) Net Income From Continuing Operations : ₩5,146 Mil (TTM As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is C&R Research Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. C&R Research's net income from continuing operations for the three months ended in Jun. 2024 was ₩1,253 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Jun. 2024 was ₩5,146 Mil.

C&R Research Net Income From Continuing Operations Historical Data

The historical data trend for C&R Research's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

C&R Research Net Income From Continuing Operations Chart

C&R Research Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Income From Continuing Operations
2,450.93 -3,304.08 3,927.56 5,559.96

C&R Research Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Net Income From Continuing Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 923.55 1,102.59 2,640.94 149.24 1,252.78

C&R Research Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩5,146 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

C&R Research Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » C&R Research Inc (XKRX:359090) » Definitions » Net Income From Continuing Operations
Comparable Companies
XKRX:347700 XKRX:263700 XKRX:032850 XKRX:390110 XKRX:099750 XKRX:071200 XKRX:226330 XKRX:032620 XKRX:315640 VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH TDOC
Traded in Other Exchanges
N/A
Address
412 Yeoksam-ro, C&R Building, Gangnam-gu, Seoul, KOR
Website
http://www.cnrres.com
C&R Research Inc provides a quotation on clinical trial service.

C&R Research Headlines

No Headlines